{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T20:25:55Z","timestamp":1790886355694,"version":"4.1.0"},"reference-count":114,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.pathol.2023.01.003","type":"journal-article","created":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T20:08:50Z","timestamp":1674245330000},"page":"269-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The diverse morphology and immunophenotype of ovarian endometrioid carcinomas"],"prefix":"10.1016","volume":"55","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4500-6679","authenticated-orcid":false,"given":"Karen L.","family":"Talia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W. Glenn","family":"McCluggage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2023.01.003_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1097\/PGP.0b013e3181c042b6","article-title":"Differences in tumor type in low-stage versus high-stage ovarian carcinomas","volume":"29","author":"K\u00f6bel","year":"2010","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/00125480-200205000-00001","article-title":"Endometrioid carcinoma of the uterine corpus: a review of its pathology with emphasis on recent advances and problematic aspects","volume":"9","author":"Clement","year":"2002","journal-title":"Adv Anat Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib4","series-title":"World Health Organization Classification of Tumours of Female Reproductive Organs","year":"2020"},{"key":"10.1016\/j.pathol.2023.01.003_bib5","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1097\/PAS.0b013e318164edf7","article-title":"Mixed ovarian epithelial carcinomas with clear cell and serous components are variants of high-grade serous carcinoma: an interobserver correlative and immunohistochemical study of 32 cases","volume":"32","author":"Han","year":"2008","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib6","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/j.1365-2559.2004.01787.x","article-title":"WT-1 assists in distinguishing ovarian from uterine serous carcinoma and in distinguishing between serous and endometrioid ovarian carcinoma","volume":"44","author":"Al-Hussaini","year":"2004","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1097\/00004347-200404000-00002","article-title":"WT1 is of value in ascertaining the site of origin of serous carcinomas within the female genital tract","volume":"23","author":"McCluggage","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1097\/00004347-200004000-00010","article-title":"Immunohistochemical detection of the Wilms\u2019 tumor gene (WT1) in epithelial ovarian tumors","volume":"19","author":"Shimizu","year":"2000","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib9","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1097\/PAS.0000000000000476","article-title":"Morphologic and molecular characteristics of mixed epithelial ovarian cancers","volume":"39","author":"Mackenzie","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib10","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1097\/PAS.0b013e3181e1a3bb","article-title":"Diagnosis of ovarian carcinoma cell type is highly reproducible: a transCanadian study","volume":"34","author":"K\u00f6bel","year":"2010","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib11","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1111\/his.12349","article-title":"Ovarian carcinoma histotype determination is highly reproducible, and is improved through the use of immunohistochemistry","volume":"64","author":"K\u00f6bel","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib12","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/PAS.0000000000001160","article-title":"FIGO versus Silverberg grading systems in ovarian endometrioid carcinoma: a comparative prognostic analysis","volume":"43","author":"Parra-Herran","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib13","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/his.13970","article-title":"Endometriosis-related pathology: a discussion of selected uncommon benign, premalignant and malignant lesions","volume":"76","author":"McCluggage","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib14","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1097\/PGP.0000000000000274","article-title":"An immunohistochemical algorithm for ovarian carcinoma typing","volume":"35","author":"K\u00f6bel","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib15","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/PGP.0b013e31829040b5","article-title":"Differential vimentin expression in ovarian and uterine corpus endometrioid adenocarcinomas: diagnostic utility in distinguishing double primaries from metastatic tumors","volume":"33","author":"Desouki","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib16","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1097\/PGP.0000000000000564","article-title":"Ovarian endometrioid carcinoma misdiagnosed as mucinous carcinoma: an underrecognized problem","volume":"38","author":"Woodbeck","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib17","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/PGP.0000000000000788","article-title":"WT1 positive ovarian endometrioid tumors: observations from consult cases and strategies for distinguishing from serous neoplasms","volume":"41","author":"Rajendran","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib18","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1097\/PGP.0b013e318182c2d2","article-title":"Increased p16 expression in high-grade serous and undifferentiated carcinoma compared with other morphologic types of ovarian carcinoma","volume":"28","author":"Phillips","year":"2009","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib19","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1097\/PAS.0b013e3181ac35f5","article-title":"Utility of p16 expression for distinction of uterine serous carcinomas from endometrial endometrioid and endocervical adenocarcinomas: immunohistochemical analysis of 201 cases","volume":"33","author":"Yemelyanova","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib20","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/PGP.0000000000000530","article-title":"Ovarian carcinoma histotype: strengths and limitations of integrating morphology with immunohistochemical predictions","volume":"38","author":"K\u00f6bel","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib21","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1038\/modpathol.2017.81","article-title":"Molecular-based classification algorithm for endometrial carcinoma categorizes ovarian endometrioid carcinoma into prognostically significant groups","volume":"30","author":"Parra-Herran","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib22","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1097\/PAS.0000000000001478","article-title":"Molecular heterogeneity of endometrioid ovarian carcinoma: an analysis of 166 cases using the endometrial cancer subrogate molecular classification","volume":"44","author":"Leskela","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1016\/j.ygyno.2019.07.012","article-title":"Molecular profiling and molecular classification of endometrioid ovarian carcinomas","volume":"154","author":"Cybulska","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pathol.2023.01.003_bib24","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1097\/PAS.0000000000001432","article-title":"Mismatch repair deficiency in ovarian carcinoma: frequency, causes, and consequences","volume":"44","author":"Leskela","year":"2020","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib25","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1097\/PAS.0000000000001798","article-title":"Accurate distinction of ovarian clear cell from endometrioid carcinoma requires integration of phenotype, immunohistochemical predictions, and genotype: implications for lynch syndrome screening","volume":"45","author":"Rodriguez","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib26","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/PAS.0000000000001165","article-title":"Incidence of mismatch repair protein deficiency and associated clinicopathologic features in a cohort of 104 ovarian endometrioid carcinomas","volume":"43","author":"Bennett","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib27","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1365-2559.2008.03083.x","article-title":"Morules in endometrioid proliferations of the uterus and ovary consistently express the intestinal transcription factor CDX2","volume":"53","author":"Houghton","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib28","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1097\/PGP.0000000000000544","article-title":"SATB2 is consistently expressed in squamous morules associated with endometrioid proliferative lesions and in the stroma of atypical polypoid adenomyoma","volume":"38","author":"McCluggage","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib29","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1097\/PAS.0000000000001934","article-title":"Morules but not squamous differentiation are a reliable indicator of CTNNB1 (\u03b2-catenin) mutations in endometrial carcinoma and precancers","volume":"46","author":"Niu","year":"2022","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib30","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/ajcp\/31.1.60","article-title":"Intraglandular morules of the endometrium","volume":"31","author":"Dutra","year":"1959","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1097\/00000478-199010000-00005","article-title":"Peritoneal keratin granulomas with carcinomas of endometrium and ovary and atypical polypoid adenomyoma of endometrium. A clinicopathological analysis of 22 cases","volume":"14","author":"Kim","year":"1990","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib32","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.currproblcancer.2018.02.001","article-title":"Primary squamous cell carcinoma arising from endometriosis of the ovary: a case report and literature review","volume":"42","author":"Xu","year":"2018","journal-title":"Curr Probl Cancer"},{"key":"10.1016\/j.pathol.2023.01.003_bib33","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1097\/PAS.0b013e3180339ed7","article-title":"Endometrioid neoplasms with clear cells: a report of 21 cases in which the alteration is not of typical secretory type","volume":"31","author":"Silva","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib34","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1097\/00004347-198512000-00005","article-title":"Secretory adenocarcinoma of the endometrium","volume":"4","author":"Tobon","year":"1985","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib35","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1097\/IGC.0000000000000275","article-title":"Comparison of pure and mixed-type clear cell carcinoma of the ovary: a clinicopathological analysis of 341 Chinese patients","volume":"24","author":"Ye","year":"2014","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.pathol.2023.01.003_bib36","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/PAT.0000000000000223","article-title":"Comparative analysis of Napsin A, alpha-methylacyl-coenzyme A racemase (AMACR, P504S), and hepatocyte nuclear factor 1 beta as diagnostic markers of ovarian clear cell carcinoma: an immunohistochemical study of 279 ovarian tumours","volume":"47","author":"Fadare","year":"2015","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib37","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1097\/PAS.0000000000000436","article-title":"Immunohistochemical comparison of ovarian and uterine endometrioid carcinoma, endometrioid carcinoma with clear cell change, and clear cell carcinoma","volume":"39","author":"Lim","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib38","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1097\/00004347-199607000-00010","article-title":"Endometrioid ciliated-cell tumors of the ovary: a report of five cases","volume":"15","author":"Eichhorn","year":"1996","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib39","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/00004347-199410000-00002","article-title":"Endometrioid carcinoma of the ovary and endometrium, oxyphilic cell type: a report of nine cases","volume":"13","author":"Pitman","year":"1994","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib40","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1097\/PAS.0b013e318216c112","article-title":"A\u00a0comprehensive analysis of PAX8 expression in human epithelial tumors","volume":"35","author":"Laury","year":"2011","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib41","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1097\/PGP.0000000000000238","article-title":"Immunohistochemistry in the diagnosis of mucinous neoplasms involving the ovary: the added value of SATB2 and biomarker discovery through protein expression database mining","volume":"35","author":"Strickland","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib42","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1177\/1066896917752861","article-title":"Comprehensive clinicopathologic and updated immunohistochemical characterization of primary ovarian mucinous carcinoma","volume":"26","author":"Bassiouny","year":"2018","journal-title":"Int J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib43","first-page":"933","article-title":"Sertoliform endometrioid carcinomas of the ovary: a clinicopathologic and immunohistochemical study of 13 cases","volume":"12","author":"Ordi","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1186\/1746-1596-7-164","article-title":"Estrogen-producing endometrioid adenocarcinoma resembling sex cord-stromal tumor of the ovary: a review of four postmenopausal cases","volume":"7","author":"Katoh","year":"2012","journal-title":"Diagn Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib45","doi-asserted-by":"crossref","first-page":"979","DOI":"10.5858\/2007-131-979-SECOTO","article-title":"Sertoliform endometrioid carcinoma of the ovary: a potential diagnostic pitfall","volume":"131","author":"Misir","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1016\/j.pathol.2023.01.003_bib46","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.1365-2559.2004.01989.x","article-title":"Immunoreactivity of ovarian juvenile granulosa cell tumours with epithelial membrane antigen","volume":"46","author":"McCluggage","year":"2005","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib47","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1097\/01.pas.0000213365.56498.72","article-title":"Ovarian sertoli-leydig cell tumors with pseudoendometrioid tubules (pseudoendometrioid sertoli-leydig cell tumors)","volume":"31","author":"McCluggage","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib48","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1097\/PGP.0000000000000775","article-title":"FIGO grade 3 endometrioid adenocarcinomas with diffusely aberrant \u03b2-catenin expression: an aggressive subset resembling cutaneous pilomatrix carcinomas","volume":"41","author":"Weisman","year":"2022","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1006\/gyno.1996.0142","article-title":"Pilomatricoma-like endometrioid adenosquamous carcinoma of the ovary with neuroendocrine differentiation","volume":"61","author":"Fang","year":"1996","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pathol.2023.01.003_bib50","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1097\/00000478-199512000-00001","article-title":"Endometrioid carcinoma of the ovary with a prominent spindle-cell component, a source of diagnostic confusion. A report of 14 cases","volume":"19","author":"Tornos","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib51","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1097\/01.pas.0000149704.89463.05","article-title":"Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms","volume":"29","author":"Murray","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib52","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1097\/PAS.0000000000001737","article-title":"Corded and hyalinized and spindled endometrioid endometrial carcinoma: a clinicopathologic and molecular analysis of 9 tumors based on the TCGA classifier","volume":"45","author":"Safdar","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib53","first-page":"149","article-title":"Aberrant nuclear beta-catenin expression in the spindle or corded cells in so-called corded and hyalinized endometrioid carcinomas. Another critical role of the unique morphological feature","volume":"24","author":"Wani","year":"2009","journal-title":"Histol Histopathol"},{"issue":"Suppl 1","key":"10.1016\/j.pathol.2023.01.003_bib54","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1097\/PGP.0000000000000512","article-title":"Issues in the differential diagnosis of uterine low-grade endometrioid carcinoma, including mixed endometrial carcinomas: recommendations from the International Society of Gynecological Pathologists","volume":"38","author":"Rabban","year":"2019","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib55","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1097\/PGP.0000000000000087","article-title":"Endometrioid adenocarcinoma of the ovary mimicking serous borderline tumor: report of a series of cases","volume":"33","author":"Mansor","year":"2014","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib56","first-page":"48","article-title":"A\u00a0case of ovarian adenosquamous carcinoma arising from endometrioid adenocarcinoma: a case report and systematic review","volume":"9","author":"Shoji","year":"2016","journal-title":"J\u00a0Ovarian Res"},{"key":"10.1016\/j.pathol.2023.01.003_bib57","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/dc.2840050115","article-title":"Adenosquamous-cell carcinoma of the ovary: report of a case with positive peritoneal fluid cytology","volume":"5","author":"Kornacki","year":"1989","journal-title":"Diagn Cytopathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib58","doi-asserted-by":"crossref","first-page":"6661","DOI":"10.4076\/1757-1626-2-6661","article-title":"Adenosquamous carcinoma of the ovary arising from endometriosis: two case reports","volume":"2","author":"Terada","year":"2009","journal-title":"Cases J"},{"key":"10.1016\/j.pathol.2023.01.003_bib59","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1097\/01.pgp.0000183048.22588.18","article-title":"Association of low-grade endometrioid carcinoma of the uterus and ovary with undifferentiated carcinoma: a new type of dedifferentiated carcinoma?","volume":"25","author":"Silva","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib60","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1038\/modpathol.2010.41","article-title":"Endometrial and ovarian carcinomas with undifferentiated components: clinically aggressive and frequently underrecognized neoplasms","volume":"23","author":"Tafe","year":"2010","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib61","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/00004347-199610000-00002","article-title":"Ovarian neuroendocrine carcinomas of non-small-cell type associated with surface epithelial adenocarcinomas. A study of five cases and review of the literature","volume":"15","author":"Eichhorn","year":"1996","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib62","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/PGP.0000000000000673","article-title":"Somatically derived yolk sac tumor of the ovary in a young woman","volume":"40","author":"Hodgson","year":"2021","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib63","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1097\/00000478-199609000-00003","article-title":"Ovarian endometrioid tumors with yolk sac tumor component, an unusual form of ovarian neoplasm. Analysis of six cases","volume":"20","author":"Nogales","year":"1996","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib64","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/his.13021","article-title":"Yolk sac tumours of the female genital tract in older adults derive commonly from somatic epithelial neoplasms: somatically derived yolk sac tumours","volume":"69","author":"McNamee","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib65","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1477-7819-12-314","article-title":"Large cell neuroendocrine carcinoma of the ovary: a case report and a brief review of the literature","volume":"12","author":"Ki","year":"2014","journal-title":"World J Surg Onc"},{"key":"10.1016\/j.pathol.2023.01.003_bib66","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1053\/j.semdp.2020.08.003","article-title":"SWI\/SNF-deficient malignancies of the female genital tract","volume":"38","author":"McCluggage","year":"2021","journal-title":"Semin Diagn Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib67","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s00428-019-02532-w","article-title":"Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas","volume":"475","author":"Franceschi","year":"2019","journal-title":"Virchows Arch"},{"key":"10.1016\/j.pathol.2023.01.003_bib68","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/PGP.0000000000000248","article-title":"Undifferentiated carcinoma of the endometrium: an expanded immunohistochemical analysis including PAX-8 and basal-like carcinoma surrogate markers","volume":"35","author":"Ramalingam","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib69","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1038\/modpathol.2016.156","article-title":"Concurrent ARID1A and ARID1B inactivation in endometrial and ovarian dedifferentiated carcinomas","volume":"29","author":"Coatham","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib70","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.pathol.2015.11.020","article-title":"BRG1-deficient dedifferentiated endometrioid adenocarcinoma of the ovary","volume":"48","author":"Tan","year":"2016","journal-title":"Pathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib71","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/his.14639","article-title":"Endometrial neuroendocrine carcinoma and undifferentiated carcinoma are distinct entities with overlap in neuroendocrine marker expression","volume":"81","author":"Tessier-Cloutier","year":"2022","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib72","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/his.13426","article-title":"Germ cell tumour growth patterns originating from clear cell carcinomas of the ovary and endometrium: a comparative immunohistochemical study favouring their origin from somatic stem cells","volume":"72","author":"Nogales","year":"2018","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib73","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1111\/his.14188","article-title":"Malignant tumours of the uterus and ovaries with Mullerian and germ cell or trophoblastic components have a somatic origin and are characterised by genomic instability","volume":"77","author":"Acosta","year":"2020","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib74","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/00000478-198710000-00004","article-title":"Endometrioid-like variant of ovarian yolk sac tumor. A clinicopathological analysis of eight cases","volume":"11","author":"Clement","year":"1987","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib75","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1111\/j.1365-2559.2011.03889.x","article-title":"Yolk sac tumours revisited. A review of their many faces and names","volume":"60","author":"Nogales","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib76","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1097\/01.MP.0000086073.92773.55","article-title":"Cdx2 protein expression in normal and malignant human tissues: an immunohistochemical survey using tissue microarrays","volume":"16","author":"Moskaluk","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib77","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/his.13772","article-title":"Nuclear \u03b2-catenin and CDX2 expression in ovarian endometrioid carcinoma identify patients with favourable outcome","volume":"74","author":"Wang","year":"2019","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib78","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1002\/cjp2.131","article-title":"A\u00a0COEUR cohort study of SATB2 expression and its prognostic value in ovarian endometrioid carcinoma","volume":"5","author":"Le Page","year":"2019","journal-title":"J\u00a0Pathol Clin Res"},{"key":"10.1016\/j.pathol.2023.01.003_bib79","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1111\/his.12332","article-title":"Thyroid transcription factor-1 (TTF-1) immunoreactivity is an adverse prognostic factor in endometrioid adenocarcinoma of the uterine corpus","volume":"64","author":"Ervine","year":"2014","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib80","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/modpathol.2008.4","article-title":"Thyroid transcription factor-1 expression in ovarian epithelial neoplasms","volume":"21","author":"Kubba","year":"2008","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib81","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11912-017-0617-2","article-title":"Pathology of neuroendocrine tumours of the female genital tract","volume":"19","author":"Howitt","year":"2017","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.pathol.2023.01.003_bib82","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/nature12113","article-title":"Integrated genomic characterization of endometrial carcinoma","volume":"497","author":"Kandoth","year":"2013","journal-title":"Nature"},{"key":"10.1016\/j.pathol.2023.01.003_bib83","doi-asserted-by":"crossref","first-page":"4995","DOI":"10.1038\/s41467-020-18819-5","article-title":"Molecular stratification of endometrioid ovarian carcinoma predicts clinical outcome","volume":"11","author":"Hollis","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.pathol.2023.01.003_bib84","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1111\/his.12543","article-title":"Ovarian and endometrial endometrioid adenocarcinomas have distinct profiles of microsatellite instability, PTEN expression, and ARID1A expression","volume":"66","author":"Huang","year":"2015","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib85","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1097\/PAS.0b013e3181a902e1","article-title":"Pathogenetic pathways in ovarian endometrioid adenocarcinoma: a molecular study of 29 cases","volume":"33","author":"Geyer","year":"2009","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib86","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/bjc.2015.190","article-title":"A\u00a0clinically applicable molecular-based classification for endometrial cancers","volume":"113","author":"Talhouk","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/j.pathol.2023.01.003_bib87","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1097\/IGC.0000000000000492","article-title":"Polymerase epsilon exonuclease domain mutations in ovarian endometrioid carcinoma","volume":"25","author":"Hoang","year":"2015","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.pathol.2023.01.003_bib88","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/his.12934","article-title":"Significant frequency of MSH2\/MSH6 abnormality in ovarian endometrioid carcinoma supports histotype-specific Lynch syndrome screening in ovarian carcinomas","volume":"69","author":"Rambau","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib89","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/cncr.23438","article-title":"Endometrioid epithelial ovarian cancer: 20 years of prospectively collected data from a single center","volume":"112","author":"Storey","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2023.01.003_bib90","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1097\/PAS.0000000000001553","article-title":"CTNNB1 mutations and aberrant \u03b2-catenin expression in ovarian endometrioid carcinoma: correlation with patient outcome","volume":"45","author":"Zyla","year":"2021","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib91","doi-asserted-by":"crossref","first-page":"dju245","DOI":"10.1093\/jnci\/dju245","article-title":"Clinical significance of CTNNB1 mutation and Wnt pathway activation in endometrioid endometrial carcinoma","volume":"106","author":"Liu","year":"2014","journal-title":"J\u00a0Natl Cancer Inst"},{"key":"10.1016\/j.pathol.2023.01.003_bib92","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/modpathol.2017.15","article-title":"CTNNB1 (beta-catenin) mutation identifies low grade, early stage endometrial cancer patients at increased risk of recurrence","volume":"30","author":"Kurnit","year":"2017","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib93","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ygyno.2014.07.100","article-title":"Lynch syndrome in patients with clear cell and endometrioid cancers of the ovary","volume":"135","author":"Vierkoetter","year":"2014","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.pathol.2023.01.003_bib94","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1097\/PAS.0b013e31823bc434","article-title":"Ovarian endometrioid adenocarcinoma: incidence and clinical significance of the morphologic and immunohistochemical markers of mismatch repair protein defects and tumor microsatellite instability","volume":"36","author":"Aysal","year":"2012","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib95","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1097\/PAS.0000000000000941","article-title":"Undifferentiated endometrial carcinomas show frequent loss of core switch\/sucrose nonfermentable complex proteins","volume":"42","author":"K\u00f6bel","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib96","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1111\/his.13248","article-title":"High-grade serous carcinoma of tubo-ovarian origin: recent developments","volume":"71","author":"Singh","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib97","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1097\/PGP.0000000000000212","article-title":"The genomic heterogeneity of FIGO grade 3 endometrioid carcinoma impacts diagnostic accuracy and reproducibility","volume":"35","author":"Hussein","year":"2016","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib98","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1097\/PAS.0b013e31827f576a","article-title":"Poor interobserver reproducibility in the diagnosis of high-grade endometrial carcinoma","volume":"37","author":"Gilks","year":"2013","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib99","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1097\/PAS.0000000000000550","article-title":"Morphological and immunohistochemical reevaluation of tumors initially diagnosed as ovarian endometrioid carcinoma with emphasis on high-grade tumors","volume":"40","author":"Lim","year":"2016","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib100","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/modpathol.2013.218","article-title":"Retinoblastoma pathway deregulatory mechanisms determine clinical outcome in high-grade serous ovarian carcinoma","volume":"27","author":"Milea","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib101","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1097\/PAS.0000000000001016","article-title":"High-grade endometrioid carcinoma of the ovary: a clinicopathologic study of 30 cases","volume":"42","author":"Assem","year":"2018","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib102","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1038\/modpathol.2016.82","article-title":"Morphologic correlates of molecular alterations in extrauterine M\u00fcllerian carcinomas","volume":"29","author":"Ritterhouse","year":"2016","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib103","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/modpathol.2011.183","article-title":"Morphologic patterns associated with BRCA1 and BRCA2 genotype in ovarian carcinoma","volume":"25","author":"Soslow","year":"2012","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib104","series-title":"WHO Classification of Tumours of Female Reproductive Organs","year":"2014"},{"key":"10.1016\/j.pathol.2023.01.003_bib105","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/his.14399","article-title":"Ovarian mucinous and seromucinous neoplasms: problematic aspects and modern diagnostic approach","volume":"80","author":"Talia","year":"2021","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib106","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/1097-0142(19880201)61:3<546::AID-CNCR2820610321>3.0.CO;2-I","article-title":"Ovarian mixed-epithelial papillary cystadenomas of borderline malignancy of mullerian type. A clinicopathologic analysis","volume":"61","author":"Rutgers","year":"1988","journal-title":"Cancer"},{"key":"10.1016\/j.pathol.2023.01.003_bib107","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1097\/01.pgp.0000177125.31046.fd","article-title":"Ovarian atypical proliferative (borderline) mucinous tumors: gastrointestinal and seromucinous (endocervical-like) types are immunophenotypically distinctive","volume":"25","author":"Vang","year":"2006","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib108","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1097\/PGP.0b013e31823f8482","article-title":"Endocervical-type mucinous borderline tumors are related to endometrioid tumors based on mutation and loss of expression of ARID1A","volume":"31","author":"Wu","year":"2012","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib109","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/01.pgp.0000152024.37482.63","article-title":"Mucinous ovarian tumors of Mullerian-type: an analysis of 17 cases including borderline tumors and intraepithelial, microinvasive, and invasive carcinomas","volume":"24","author":"Dub\u00e9","year":"2005","journal-title":"Int J Gynecol Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib110","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1097\/01.pas.0000138178.10829.b8","article-title":"Endocervical-like mucinous borderline tumors of the ovary: a clinicopathologic analysis of 31 cases","volume":"28","author":"Rodriguez","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib111","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1097\/PAS.0000000000000405","article-title":"Ovarian seromucinous carcinoma: report of a series of a newly categorized and uncommon neoplasm","volume":"39","author":"Taylor","year":"2015","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib112","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1097\/PAS.0000000000000812","article-title":"Morphologic reproducibility, genotyping, and immunohistochemical profiling do not support a category of seromucinous carcinoma of the ovary","volume":"41","author":"Rambau","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pathol.2023.01.003_bib113","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1111\/his.12895","article-title":"Hormone receptor-negative, thyroid transcription factor 1-positive uterine and ovarian adenocarcinomas: report of a series of mesonephric-like adenocarcinomas","volume":"68","author":"McFarland","year":"2016","journal-title":"Histopathology"},{"key":"10.1016\/j.pathol.2023.01.003_bib114","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1097\/PAP.0000000000000342","article-title":"Mesonephric-like adenocarcinoma of the female genital tract: from morphologic observations to a well-characterized carcinoma with aggressive clinical behavior","volume":"29","author":"McCluggage","year":"2022","journal-title":"Adv Anat Pathol"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523000314?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302523000314?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T16:29:53Z","timestamp":1758472193000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302523000314"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":114,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S0031302523000314"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2023.01.003","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The diverse morphology and immunophenotype of ovarian endometrioid carcinomas","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2023.01.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}